ATG9A and neoplasm: To better define how tumor-targeting macrophages eliminate cancer cells, dual co-culture CRISPR screens in ovarian cancer models using distinct CAR-macrophages both identify ATG9A as a regulator whose loss increases tumor death after direct macrophage contact, independent of phagocytosis.